2013
DOI: 10.1016/j.celrep.2013.08.003
|View full text |Cite
|
Sign up to set email alerts
|

DREADDs in Drosophila: A Pharmacogenetic Approach for Controlling Behavior, Neuronal Signaling, and Physiology in the Fly

Abstract: SUMMARY We have translated a powerful genetic tool, designer receptors exclusively activated by designer drugs (DREADDs), from mammalian systems to Drosophila melanogaster to selectively, rapidly, reversibly, and dose-dependently control behaviors and physiological processes in the fly. DREADDs are muscarinic acetylcholine G protein-coupled receptors evolved for loss of affinity to acetylcholine and for the ability to be fully activated by an otherwise biologically inert chemical, clozapine-N-oxide. We demonst… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
30
0

Year Published

2013
2013
2018
2018

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 42 publications
(31 citation statements)
references
References 48 publications
1
30
0
Order By: Relevance
“…To date, hM4Di (for silencing) and hM3Dq (for activating) neurons have been the most frequent used DREADDs. DREADDs have been used to modulate neural activity and behavior in flies (Becnel et al, 2013), mice (Alexander et al, 2009), rats (Ferguson et al, 2011), and nonhuman primates (Eldridge et al, 2016). Although DREADD technology has clearly been useful, there are several ways in which the technological platform could be enhanced.…”
Section: Areas For Enhancement Of Dreadd Technologiesmentioning
confidence: 99%
“…To date, hM4Di (for silencing) and hM3Dq (for activating) neurons have been the most frequent used DREADDs. DREADDs have been used to modulate neural activity and behavior in flies (Becnel et al, 2013), mice (Alexander et al, 2009), rats (Ferguson et al, 2011), and nonhuman primates (Eldridge et al, 2016). Although DREADD technology has clearly been useful, there are several ways in which the technological platform could be enhanced.…”
Section: Areas For Enhancement Of Dreadd Technologiesmentioning
confidence: 99%
“…DREADD knock-in animal models, including Drosophila and mice, are currently being used by the GPCR research community for engaging celltype selective G protein signaling. For example, the selective expression of DREADDs in the Drosophila heart clarified the signal pathway of the 5-HT receptor in the control of heartbeat (Becnel et al, 2013;Majeed et al, 2013). DREADD/cloxipinenitric oxide pharmacology does not provide spatial-temporal control; however, there is no need for complex fiber/light-emitting diode systems or expensive microscopy, and this approach has therefore gained a wide user base.…”
Section: Model Organisms In Gpcr Researchmentioning
confidence: 99%
“…We then confirm that SP is largely responsible for inducing this decrease, and demonstrate that the canonical sex peptide receptor (SPR) is necessary and acts in specific neurons to alter postmating sleep. Using a pharmacogenetic approach (Becnel et al, 2013), we establish that silencing the "canonical" SPSN-SAG postmating circuit is sufficient to decrease female sleep. Finally, experiments ablating the SPSN neurons suggest mechanistic differences in some PMRs.…”
mentioning
confidence: 99%